Answers are grounded in this paper and cite their sources.
// Hong Ding 1, * , Jianlu Wei 1, * , Yunpeng Zhao 1 , Yi Liu 1 , Lian Liu 1 and Lei Cheng 1 1 Department of Orthopaedics, Qilu Hospital of Shandong University, Jinan, China * These authors have contributed equally to this work Correspondence to: Lei Cheng, email: chengleiyx@126.com Keywords: Atsttrin; TNF-α; progranulin; intervertebral disc degeneration; inflammation Received: September 06, 2017 Accepted: October 29, 2017 Published: November 29, 2017 ABSTRACT Atsttrin, an engineered molecule composed of three fragments of progranulin(PGRN), exerts comparable anti-inflammation ability. Intervertebral disc degeneration (IDD) is involved in inflammation in which TNF-α plays a key role. This study aims to examine the effect and the mechanism of Atsttrin in the pathogenesis of intervertebral disc degeneration. For this purpose, we took advantage of murine and human intervertebral disc (IVD) and examined the expression of TNF-α in IVD tissues using immunohistochemistry and TNF-α level in peripheral sera by ELISA assay. Moreover, murine IVD was taken to undergo the Safranin O and HE staining. Furthermore, primary human nucleus pulposus cells were used for immunohistochemistry staining, fluorescent staining, Western Blot, ELISA assay and RT-PCR assay. Herein we found TNF-α expression was elevated in intervertebral disc and peripheral sera in patients with IDD. Interestingly, Atsttrin effectively inhibited TNF-α-mediated catabolism in murine disc by ex vivo study. TNF-α-induced inflammatory cytokines were strongly reduced in presence of Atsttrin in primary human disc. Mechanism study indicated Atsttrin protected against intervertebral disc degeneration by inhibiting TNF-α-induced inflammation. These findings show that Atsttrin is a potential molecular target for disc degenerative diseases.
No takes yet. Share an insight, caveat, or question.
Ding et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: